Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000413113 | SCV000491855 | uncertain significance | not provided | 2016-11-16 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the SNTA1 gene. The R197W variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The R197W variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, however, it was observed in approximately 0.15-0.20% of alleles from individuals of East Asian ancestry in the 1000 Genomes Project and Exome Aggregation Consortium, indicating it may be a rare benign variant in this population. Additionally, this substitution occurs at a position that is not conserved across species and Tryptophan is tolerated at this position in at least two species. Finally, while R197W is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function.Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or rare benign. |
| Invitae | RCV000529567 | SCV000627700 | likely benign | Long QT syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV000621647 | SCV000736381 | likely benign | Cardiovascular phenotype | 2023-05-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Blueprint Genetics | RCV000157504 | SCV000207249 | uncertain significance | Ventricular fibrillation, paroxysmal familial, type 1 | 2014-09-24 | no assertion criteria provided | clinical testing |